Health Care & Life Sciences » Pharmaceuticals | Heron Therapeutics Inc.

Heron Therapeutics Inc.

Heron Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.47
Market Cap
$1.45 B
Shares Outstanding
79.19 M
Public Float
77.53 M

Profile

Address
4242 Campus Point Court
San Diego California 92121
United States
Employees -
Website http://www.herontx.com
Updated 07/08/2019
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011.

Financials

View All

Kevin C. Tang
Chairman
Robert H. Rosen
President & Director